Gian Lifecare Ltd
Incorporated in 2018, Kanpur (UP) based Gian Life Care Limited is engaged in the business of providing diagnostic and related healthcare services. The company caters to individual patients, hospitals, corporates and other healthcare providers.
- Market Cap ₹ 24.0 Cr.
- Current Price ₹ 23.2
- High / Low ₹ 29.0 / 18.2
- Stock P/E 5.58
- Book Value ₹ 19.0
- Dividend Yield 0.00 %
- ROCE 29.1 %
- ROE 24.6 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -3.26%
- Promoters have pledged 26.5% of their holding.
- Debtor days have increased from 91.8 to 134 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
0.56 | 7.31 | 10.24 | 15.45 | 11.92 | 13.12 | |
0.36 | 5.23 | 7.14 | 9.39 | 9.90 | 6.94 | |
Operating Profit | 0.20 | 2.08 | 3.10 | 6.06 | 2.02 | 6.18 |
OPM % | 35.71% | 28.45% | 30.27% | 39.22% | 16.95% | 47.10% |
0.00 | 0.10 | 0.29 | 0.51 | 0.69 | 0.64 | |
Interest | 0.04 | 0.37 | 0.35 | 0.39 | 0.43 | 0.45 |
Depreciation | 0.02 | 0.26 | 0.29 | 0.33 | 0.50 | 0.46 |
Profit before tax | 0.14 | 1.55 | 2.75 | 5.85 | 1.78 | 5.91 |
Tax % | 21.43% | 28.39% | 26.91% | 25.30% | 29.78% | 27.24% |
0.10 | 1.13 | 2.02 | 4.37 | 1.26 | 4.30 | |
EPS in Rs | 1.10 | 1.96 | 4.23 | 1.22 | 4.16 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 88% |
3 Years: | 9% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 112% |
3 Years: | 29% |
TTM: | 241% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 15% |
1 Year: | 13% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 23% |
Last Year: | 25% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 0.01 | 4.70 | 4.70 | 10.34 | 10.34 | 10.34 |
Reserves | 0.10 | 2.94 | 4.96 | 3.69 | 4.97 | 9.27 |
1.36 | 1.09 | 1.00 | 2.03 | 4.58 | 4.16 | |
6.34 | 3.64 | 4.82 | 7.00 | 8.51 | 8.30 | |
Total Liabilities | 7.81 | 12.37 | 15.48 | 23.06 | 28.40 | 32.07 |
2.91 | 2.84 | 2.99 | 3.50 | 4.61 | 4.46 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.14 |
Investments | 0.00 | 0.00 | 0.00 | 0.11 | 0.11 | 0.11 |
4.90 | 9.53 | 12.49 | 19.33 | 23.54 | 27.36 | |
Total Assets | 7.81 | 12.37 | 15.48 | 23.06 | 28.40 | 32.07 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
2.99 | 1.51 | 2.87 | 5.79 | 2.32 | 0.75 | |
-2.92 | -3.96 | -1.10 | -4.23 | -0.94 | 0.33 | |
0.96 | 2.55 | -0.39 | 0.67 | -0.37 | -0.86 | |
Net Cash Flow | 1.03 | 0.10 | 1.38 | 2.23 | 1.01 | 0.22 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 860.36 | 78.39 | 73.07 | 42.05 | 99.52 | 133.81 |
Inventory Days | 4,380.00 | 116.38 | 182.50 | |||
Days Payable | 5,266.43 | 379.55 | 636.68 | |||
Cash Conversion Cycle | -26.07 | 78.39 | 73.07 | 42.05 | -163.65 | -320.36 |
Working Capital Days | -2,887.41 | -40.44 | -52.04 | -31.42 | -63.69 | -1.39 |
ROCE % | 37.65% | 31.98% | 46.71% | 12.29% | 29.13% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
20 Jul - Pls find attached herewith Certificate under Reg 74(5) of Gian Life Care Limited for the period ended June 30, 2024.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Newspaper publications regarding publication of Audited Standalone and Consolidated Financial Results for the quarter/ half year/ year ended March 31, 2024.
- Audited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year And Year Ended 31St March, 2024 30 May
- Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, May 30, 2024 30 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual Secretarial Compliance Report for the year ended March 31, 2024.
Annual reports
Concalls
-
Nov 2021TranscriptNotesPPT
Business Overview:[1]
Company provides diagnostic and related
healthcare tests and services in Kanpur
and nearby areas. Company provides diagnostic and related healthcare tests and services viz. patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. Company is in process to open several diagnostics labs in various parts of country. Another major lab in Lucknow also became operational in April, 2022